> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Drug Compounding Information Collection Revision
- URL: https://www.fdaweb.com/drug-compounding-information-collection-revision/
- Published: 2022-06-17T12:00:00.000Z
- Updated: 2026-09-14T17:49:10.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5152101

*Federal Register* notice: FDA is seeking comments on an information collection revision entitled “Human Drug Compounding Under Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act” (OMB Control Number 0910-0800). The revision addresses outsourcing facility registrations and the need to submit certain reports and updates to FDA. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2022-06-17/pdf/2022-13068.pdf?ref=fdaweb.com).